Search

Search Constraints

You searched for: Author/Creator Engelhardt, E.

Search Results

2. The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe. (November 2022)

3. Women diagnosed with Ductal Carcinoma In Situ (DCIS) and healthcare providers' views on active surveillance for DCIS. Results from focus groups and in-depth interviews. (October 2020)